Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Odyssey and Dharmacon investigate effects of siRNA-induced gene silencing

Sep. 18, 2003

Panacea expands research agreement with MIT

Sep. 17, 2003

New trial approved to evaluate GTI-2040 in combination with docetaxel for NSCLC

Sep. 17, 2003

Efficacy of drug for dry mouth in preventing lung cancer claimed in recent patent

Sep. 17, 2003

DOS-47 demonstrates preclinical antitumor activity

Sep. 17, 2003

Market launch announced for Aloxi

Sep. 16, 2003

Advisory committee does not recommend approval of Metvix for basal cell carcinoma

Sep. 16, 2003

Bioenvision obtains clofarabine option in Japan and South East Asia

Sep. 16, 2003

Philip Morris grant supports TNT-based lung cancer research

Sep. 16, 2003

Vitaxin enters phase II trials in melanoma and rheumatoid arthritis

Sep. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...